REMS assessments found no cases of Torsades de pointes or unexplained sudden deaths among patients taking vandetanib during more than a decade of oversight, regulators said.

The UK’s Debt Management Office (DMO) only managed to sell £4.75 billion in five-year government debt on Wednesday, but the demand came in at the weakest ...

However, the FDA said that after over more than a decade of oversight, REMS assessments reported no cases of torsades de pointes or unexplained sudden deaths among U.S. patients taking vandetanib, ...

FDA lifts REMS program for vandetanib, affirming safety in thyroid cancer treatment as healthcare providers ensure effective heart rhythm monitoring. The FDA has removed the risk evaluation and ...

Yields on 30-year US bonds have fallen around 25 basis points since early September, while those on UK gilts have dropped 20 basis points and their Japanese counterparts have fallen nearly 15 basis ...

Hidden cardiac conditions can exist silently - sometimes showing up only during intense physical activity. Even those who appear fit and active may be at risk of sudden cardiac events.

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

A battle over diversity, equity and inclusion is costing Hartsfield-Jackson Atlanta International Airport $57 million.

Moscow, Russia's leading tourist city, celebrated World Tourism Day on September 27. Each year, the Russian capital enhances its tourism infrastructure, improves services, and strengthens its tourism ...

Acadia Pharmaceuticals Inc. was downgraded after a drug setback, but strong sales and a robust pipeline offer investment potential. Click for my ACAD update.

The move targets recurring corporate travel, giving employers controls over where, when and how staff use autonomous rides, as Waymo broadens commercial uses for its driverless fleet. Waymo said it ...

The REMS program for vandetanib in the treatment of patients with medullary thyroid cancer has been removed by the FDA.